Istvan Petak, MD, PhD profile page

Dr. Istvan Petak is an international expert in precision oncology and molecular pharmacology of targeted therapies with over 30 years of experience. He is the founder and CSO of Genomate Health, Inc., Cambridge, MA, co-founder of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC). He started his molecular pathology and signal transduction therapy career at Semmelweis University and St. Jude Children's Research Hospital (Memphis, TN). His main achievements are exploring the role of apoptotic pathways in individual drug sensitivity, pioneering molecular companion diagnostics of the EGFR gene in 2003, and implementing NGS (next-generation sequencing) in precision oncology in 2008. He is the lead inventor of a novel computational method, published in 2021, for standardized and personalized treatment recommendations, which has won numerous recognitions from organizations, including DIGITALEUROPE and ASCO.